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valves caused by venous thrombosis or as a result of under-
lying degenerative changes in the venous wall, as in the
case of varicose veins. It is, therefore, important to include
the contralateral limb in long-term studies to determine
whether the patient has an underlying venous disease
affecting the overall outcome.11
This study was designed to examine the long-term
clinical outcome after acute DVT. The clinical results of
the ipsilateral and contralateral limbs were compared to
determine whether the presence of an underlying venous
disease is a prediction of a more severe clinical outcome
and to examine what other factors may play a part in the
pathogenesis of CVI.
METHODS AND MATERIALS
A total of 100 consecutive above-knee acute DVTs at
our vascular laboratory were examined. The presence of an
acute DVT was diagnosed with bilateral venous duplex
scanning.12 The patients underwent follow-up examina-
tions at 1 week, 1 month, 6 months, 1 year, and then
yearly for a mean period of 3 years. The study was
approved by the Institutional Review Board, and each
patient gave informed consent before participating in the
study. Bilateral reflux studies were performed at follow-up
examinations by the use of the distal cuff deflation tech-
nique to determine the level of reflux, obstruction, or
The post-thrombotic syndrome (PTS) is one of the
most serious long-term complications of deep venous
thrombosis (DVT) in the lower limb. The PTS occurs in
60% to 70% of cases in which patients are monitored for
between 5 and 10 years after conservative treatment of
DVT.1-3 However, 20% to 30% of limbs have no signs or
symptoms after DVT, and 32% of the contralateral limbs,
without DVT, have positive signs and symptoms.4-6 It is
unknown why some patients have a post-thrombotic limb,
whereas others remain without symptoms.
It is well established that valvular incompetence in the
deep venous systems and in the perforating veins is the
predominant factor in the development of chronic venous
insufficiency (CVI).1,2,7-10 The site and extent of venous
reflux are important in the clinical severity of CVI.7,8,10
Venous incompetence can occur because of damage to the
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Purpose: This study was designed to determine whether patients having underlying venous disease in their contralateral
limbs indicates a more severe long-term clinical outcome in the ipsilateral limb after a deep vein thrombosis (DVT) and
to determine what other factors may influence the long-term outcome.
Methods: An acute DVT was initially diagnosed by means of duplex ultrasound scanning. Follow-up clinical examina-
tions and bilateral duplex reflux studies were performed for a mean period as long as 3 years. The patients were divided
into two groups: group I, those with no history of a contralateral DVT, and group II, those with a history of a con-
tralateral DVT. The patients were classified at their final examination according to the Clinical, Etiology, Anatomic,
Pathophysiologic (CEAP) classification, and the ipsilateral and contralateral limbs were compared. Predisposing factors
were compared with the final clinical outcome.
Results: Sixty-three patients were monitored in a mean follow-up period of 3 years. There was a significant difference
in the incidence of symptoms between the ipsilateral limbs (P < .01) and the contralateral limbs (P < .001) for both
groups. There was no significant difference between the incidence of superficial reflux between the ipsilateral and con-
tralateral limbs, but the deep venous system and perforator veins were involved more often in the ipsilateral limbs. In
group I, only six patients (10%) had no evidence of venous dysfunction (CEAP = 0) in their ipsilateral or contralateral
limbs at the time of the final examination, and all patients had reversible risk factors. Of patients who had a mild clin-
ical outcome (CEAP score, 1 to 3), 64% had a healthy contralateral limb, and the remaining 36% had mild to moder-
ate disease. Eighty percent of patients with the most severe clinical outcome (CEAP > 3) had mild to moderate venous
disease in their contralateral limb and had nonreversible risk factors.
Conclusion: There are a significant number of patients with an acute DVT who had an underlying venous disease in the
uninvolved contralateral limb. An ipsilateral post-thrombotic limb is more likely to develop in patients with primary
venous reflux after an acute DVT. The level of venous dysfunction in the contralateral limb is an indication of the sever-
ity of disease developing in the ipsilateral limb. The initial risk factors of the patients have an influence on the final
clinical outcome. (J Vasc Surg 2001;34:247-53.)
both in the superficial, perforator, and deep venous sys-
tems.13,14 The early results of this study have been
reported.15-17 At yearly examinations, the patients were
also examined clinically, and symptoms were recorded.
The patients were divided into two groups: group I
consisted of those without a history of a contralateral
DVT, and group II consisted of those with a history of a
contralateral DVT. The patient symptoms, venous systems
involved (ie, deep, superficial, or perforator), and anatom-
ical site of venous dysfunction were compared in the ipsi-
lateral and contralateral limbs for the two groups.
The Clinical, Etiology, Anatomic, Pathophysiologic
(CEAP) classification system was used to classify and grade
the severity of the clinical findings at the final examina-
tion.18 An overall subjective venous dysfunction CEAP
score that was composed of a clinical severity score, an
anatomical severity score, and a disability severity score as
experienced by the patient was given for each limb (Table
I). For simplicity, the anatomical score was given for over-
all superficial, deep, or perforator system involvement and
not for the individual anatomical sites. The two groups of
patients were subdivided according to their total CEAP
score on the ipsilateral limb, and the ipsilateral and con-
tralateral limbs were then compared. The subdivisions
were (1) total CEAP score ipsilateral limb = 0, no venous
disease; (2) total CEAP score ipsilateral limb = 1 to 3
inclusive, mild to moderate venous disease; and (3) total
CEAP ipsilateral limb score more than 3, severe venous
disease. The initial predisposing factors for the patients
were then compared with their final CEAP classification.
RESULTS
There were initially 100 proximal DVTs in 89 patients
(11 bilateral thromboses). At 1 year, 14 patients had died,
and 23 patients were lost to follow-up. The causes of
death were cancer (10), pulmonary embolism (3), and
heart disease (1). The long-term results of the remaining
63 patients are presented in this report. None of these 63
patients initially had a bilateral DVT.
The 63 patients included 34 men and 29 women, with
a mean age of 62 years (range, 22-94 years). The mean
follow-up period was 3 years (range, 2-6 years). The
patients were treated by their referring physicians, with no
therapeutic recommendations from the vascular labora-
tory. The therapeutic regimen consisted of heparin (either
subcutaneous or intravenous) for a period of 5 to 7 days,
followed by at least 3 months of orally administered war-
farin. Compression stockings were supplied, but compli-
ance of use was low, and only 20 patients wore the
stockings as instructed.
Most patients initially had a combination of risk fac-
tors. Two patients were proven to have an abnormality in
the coagulation system (ie, factor V Leiden carriers).
However, because only a small number of patients in this
study had a thrombophilia screen, coagulation abnormali-
ties that may have been present in this patient population
could not be included in the risk factor assessment. Three
patients had a history of an earlier bilateral DVT. A total
of 16 limbs (25%) had a history of an ipsilateral DVT, and
17 limbs (27%) had a history of a contralateral DVT. The
predisposing factors of the patient population are shown
in Fig 1. There were 46 patients in group I and 17 patients
in group II.
Patients with symptoms at the final examination gen-
erally had a combination of symptoms that included
aching, pain, edema, and ulcers (all healed at the time of
the final examination). Only one patient complained of
pain in both lower extremities. No underlying cause (eg,
arterial disease) was established for this. The symptoms on
follow-up in the ipsilateral and contralateral limb for
group I and group II are shown in Table II. There is a sig-
nificant difference between group I and group II in the
number of patients with symptoms in their ipsilateral limb
(P < .01) and the number of patients with symptoms in
their contralateral limb (P < .001).
Sites of reflux and obstruction in the ipsilateral and
contralateral limbs were identified by means of duplex
ultrasound scanning (Table III). There was no significant
difference between the percentage of abnormalities in the
ipsilateral limbs in group I and group II; however, there
was a significant difference in the percentage of abnormal-
ities present in the contralateral limbs between the two
groups (P < .001).
The anatomical sites of venous dysfunction involving
the superficial, perforator, and deep venous systems in the
ipsilateral and contralateral limbs for both groups are
shown in Table IV. In group I, there was no significant
difference in the incidence of superficial system involve-
ment between the ipsilateral and contralateral limbs; how-
ever, there was a significant difference in the incidence of
deep venous system and perforator vein involvement (P <
.001 and P < .05, respectively). For group II, there was no
significant difference in the involvement of the superficial
or perforator system between the ipsilateral and contralat-
eral limbs, but there was a significant difference in the inci-
dence of deep venous system involvement (P < .04). In the
comparison of group I and group II, there was no signifi-
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Fig 1. Percentage of initial predisposing factors of patient
population.
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Table I. The CEAP scoring system of chronic venous dysfunction based on an anatomic score, clinical score, and disability score
Anatomical score
(1 point each)
Superficial
Deep
Perforator
Subtotal
Clinical score
(none = 0; mild/moderate = 1; severe = 2)
Pain
Edema
Venous claudication
Pigmentation
Lipodermatosclerosis
Ulcer size
Ulcer duration
Ulcer recurrence
Ulcer number
Subtotal
Disability
Asymptomatic = 0
Symptomatic, can function without support device = 1
Can work 8-hour d only with support device = 2
Unable to work = 3
Subtotal
Total score
Table II. The percentage of patients in group I and group II with symptoms on follow-up in the ipsilateral and con-
tralateral limb
Group I Group II
Ipsilateral Contralateral Ipsilateral Contralateral
Percentage of total with symptoms 56% 2% 88% 71%
No. of patients with pain 0 0 1 0
No. of patients with edema 32 3 14 10
No. of patients with pigmentation 14 4 11 8
No. of patients with ulcer 3 0 0 0
Most patients had a combination of symptoms, and the number of patients with pain, edema, pigmentation, and history of an ulcer is also shown. There is
a significant difference in the percentage of patients with symptoms in their ipsilateral limbs (P < .01) and the percentage of patients with symptoms in their
contralateral limbs (P < .001) between group I and group II.
Table III. The number of ipsilateral and contralateral limbs with reflux, obstruction, both reflux and obstruction, or
no venous abnormalities for both groups
Group I (N = 46) Group II (N = 17)
None Reflux Obstruction Both None Reflux Obstruction Both
Ipsilateral 6 15 1 24 0 9 0 8
Contralateral 26 18 2 0 2 11 4 0
There was no significant difference between the number of abnormalities in the ipsilateral limbs between groups I and II; however, there was a significant
difference in the number of abnormalities present when the two contralateral limbs are compared (P < .001).
cant difference between the incidences of venous dysfunc-
tion in the ipsilateral limbs, but in the contralateral limbs,
there was a higher incidence of deep venous and perfora-
tor system involvement for group II.
The anatomical sites of venous incompetence or
obstruction in the ipsilateral and contralateral limbs are
shown in Table V. Because of the difficulty of imaging the
inferior vena cava, the common iliac, and internal iliac
veins, these sites were not included in many patients. Most
patients had multiple sites of reflux, obstruction, or both.
The most frequent anatomical sites involved in both the
ipsilateral and contralateral limbs for both groups were the
long saphenous veins, the superficial femoral veins, the
popliteal veins, and the calf perforator veins.
The two groups of patients were divided according to
their total CEAP score in the ipsilateral limb (Table I).
The CEAP scores of the ipsilateral and contralateral limbs
were compared for group I and group II and are shown in
Table VI. The initial predisposing factors were compared
with the classification according to the CEAP score, and
this comparison is shown in Fig 2.
DISCUSSION
Post-thrombotic manifestations develop as a result of
combined deep and superficial venous reflux, the extent of
venous reflux, recurrent deep venous thrombotic events,
and persistent deep venous occlusion.2,4,10,19 After a
DVT, post-thrombotic symptoms develop in many
patients; however, reflux may not develop in as many as
50% of venous segments that recanalize, and the initial
location and extent of a thrombus may not relate to the
long-term sequelae.3,4,7,11,20
We studied a consecutive series of 100 acute DVTs for
a mean period as long as 3 years to examine the factors
influencing post-thrombotic development. The mortality
rate of the patients was 14% at 1 year. Most deaths were
from cancer, and only 3% were caused by pulmonary
embolism. This is a similar rate to that of other studies that
report a mortality range as high as 15% during the first
year, primarily because of an underlying disease such as
cancer.21,22
One of the long-term complications of DVT is recur-
rence. The risk of recurrent venous thrombosis has been
reported to be as high as 20%.17,21,23,24 Of the 63 patients
available for long-term follow-up, 25% had a history of an
ipsilateral DVT and 27% had a history of a contralateral
DVT (5% bilateral). These histories were not always con-
firmed by means of objective testing. Also, the history of
an occult DVT cannot be ruled out in either limb. The
patients were divided into two groups, those without a
history of a contralateral DVT and those with a history of
a contralateral DVT (or bilateral post-thrombotic limbs).
The clinical manifestations of the post-thrombotic
syndrome are hyperpigmentation, edema, pain, and ulcer-
ation. There was a significant difference in the incidence of
symptoms in the contralateral limbs between group I and
group II (P < .001). This is not surprising, because the
contralateral limbs in group II were post-thrombotic.
However, in the ipsilateral limbs, there was also a signifi-
cant difference in the incidence of symptoms between
group I and group II (P < .01), indicating that symptoms
are more likely to develop during follow-up in patients
with bilateral disease.
Symptomatic chronic venous disease results primarily
from venous valvular insufficiency.7,8,10,19 The presence of
reflux, obstruction, or both was confirmed by means of
duplex scanning and reflux studies. In both groups, the
ipsilateral limbs had a higher incidence of combined reflux
and obstruction (because of residual thrombus) than the
contralateral limbs. However, the contralateral limbs in
group I had an incidence of reflux similar to that in the
ipsilateral limbs. Because these patients had no clinical his-
tory of DVT in their contralateral limb, degenerative
changes not related to the DVT were the most likely cause
for the development of reflux.
It has been reported that the sites of venous dysfunc-
tion are not always related to the sites of DVT.7,8,10,19,25
CVI can result from a primary as well as a post-thrombotic
cause, although occult thrombosis cannot be excluded.
For both groups of patients, in the ipsilateral and con-
tralateral limbs, the most common sites of venous dys-
function were the long saphenous veins, the superficial
femoral veins, the popliteal veins, and the perforator veins.
The anatomical site of reflux is important because the
most severe symptoms are found in patients with incom-
petence in the distal deep and superficial veins.7,25-28
Superficial venous incompetence may occur in the post-
thrombotic limb because of concurrent thrombosis,
increased venous pressure resulting from proximal venous
obstruction or reflux, pressure transmission through
incompetent perforator veins, or degenerative changes
occurring in the superficial veins that are unrelated to the
thrombotic event.27,29 Meissner et al27 have reported that
approximately 22% of limbs with DVT have related con-
current superficial thrombosis that may account for the
development of reflux in some of the long saphenous
veins. However, there was no significant difference in the
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Fig 2. Percentage of predisposing factors in relation to total
CEAP score on ipsilateral limb.
incidence of superficial venous system involvement
between the ipsilateral and contralateral limbs in group I,
suggesting an underlying venous disease may more likely
be the cause of reflux. Long saphenous reflux in the unin-
volved extremity contralateral to a DVT develops at a
background rate of approximately 15% in 8 years, which is
likely related to degenerative changes within the vein
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because it has a similar rate of the prevalence of reflux in
the general population.27 All limbs with a history of DVT
had a higher incidence of deep venous system involve-
ment.
The CEAP classification provides a uniform means of
classifying and grading the severity of the clinical findings
and is a useful method in any long-term study.18 The clas-
Table IV. The number of ipsilateral and contralateral limbs involving the superficial, deep, and perforator venous 
systems in both groups on follow-up
Group I Group II
Superficial Deep Perforator Superficial Deep Perforator
Ipsilateral 22 41 22 8 15 10
Contralateral 17 8 12 7 12 10
P value NS < .001 < .05 NS < .04 NS
In group I, there was a significant difference between the ipsilateral and contralateral limb in the incidence of involvement of the deep and perforator sys-
tems (P < .001 and P < .05). In group II, there was a significant difference in the incidence of involvement of the deep venous system only (P < .04).
NS, Not significant.
Table V. The number of anatomical sites of venous dysfunction (either incompetence or obstruction) in the contralateral
and ipsilateral limbs for both groups
No. of limbs
Group I Group II
Ipsilateral Contralateral Ipsilateral Contralateral
Telangiectase/reticular veins 2 (4%) 1 (2%) 1 (6%) 1 (6%)
LSV AK 17 (37%) 10 (22%) 6 (35%) 8 (47%)
LSV BK 10 (22%) 6 (13%) 7 (41%) 5 (29%)
SSV 8 (17%) 0 0 0
Nonsaphenous 1 (2%) 0 0 0
Iliac external 1 (2%) 0 0 0
Femoral common 4 (9%) 2 (4%) 3 (18%) 0
Femoral deep 2 (4%) 1 (2%) 1 (6%) 0
Femoral superficial 27 (59%) 7 (15%) 15 (88%) 9 (53%)
Popliteal 32 (70%) 10 (22%) 16 (94%) 10 (59%)
Cureal 8 (17%) 1 (2%) 1 (6%) 1 (6%)
Muscular 7 (15%) 1 (2%) 2 (12%) 1 (6%)
Perforator—thigh 3 (6%) 2 (4%) 1 (6%) 0
Perforator—calf 20 (43%) 15 (33%) 10 (59%) 7 (41%)
LSV AK, Long saphenous vein above the knee; LSV BK, long saphenous vein below the knee; SSV, short saphenous vein.
Table VI. The CEAP total score for the ipsilateral and contralateral limb on follow-up for the two groups
Contralateral limb
Group I Group II
Ipsilateral limb 0 1 2 3 4 5 6 0 1 2 3 4 5 6
CEAP score
0 (N = 6) 6
1-3 (N = 22) 14 3 1 1 1 1 1
> 3 (N = 35) 7 5 4 3 0 2 1 1 1 1 4 3 3
sification addresses the clinical, etiologic, anatomic, and
pathophysiologic mechanisms and requires objective test-
ing to support these diagnoses. In group II, there was a
similar distribution of CEAP scoring between the ipsilateral
and contralateral limbs. In group I, six limbs had a CEAP
score of 0 on both sides. Of the patients who had mild to
moderate disease in the ipsilateral limb (CEAP 1 to 3), 64%
had a healthy contralateral limb, and the remaining 36%
had mild to moderate disease. Of the patients with severe
venous disease (CEAP score > 3), only 20% had healthy
contralateral limbs, and the remaining 80% had mild to
severe disease. This means that the severity of the disease
on the contralateral limb was related to the severity of the
post-thrombotic changes recorded on the ipsilateral limb.
These results indicate that symptoms in the ipsilateral limb
are more likely to develop in patients with nonthrombotic
venous disease in the contralateral limb.
The CEAP scoring system does not take into account
the history of the patient; however, risk factors play an
important part in the long-term prognosis. Patients with
temporary risk factors (eg, recent surgery and trauma)
have an excellent long-term prognosis.21 Thrombosis
manifests itself as a multicausal disease and generally devel-
ops with a combination of risk factors.30,31 Few patients in
this study had only a single risk factor. The risk of devel-
oping a post-thrombotic limb is higher for patients with
permanent risk factors than for patients who have had
trauma or undergone surgery.21 The six patients who had
bilateral healthy venous systems on follow-up all had
reversible risk factors. Patients with a history of varicose
veins or a history of earlier DVT, either contralateral or
ipsilateral, had a higher final CEAP score. Of those
patients with a history of earlier DVT, only five had this as
a single risk factor.
The clinical manifestations of CVI are often referred
to as the PTS. Patients with recurrent DVTs are at high
risk for the development of the PTS.21 However, an ear-
lier episode of DVT is not a prerequisite for the develop-
ment of the syndrome.19 Venous hypertension, which is a
universal element of the syndrome, can derive from pri-
mary as well as post-thrombotic venous reflux. The pres-
ence of reflux in the uninvolved contralateral limb without
a history of an earlier DVT suggests an underlying venous
disease and can lead to a more severe clinical outcome for
the patient. Other factors also play a role in the pathogen-
esis of CVI. The initial risk factors for the development of
a DVT have a strong influence on the long-term outcome.
In conclusion, a significant number of patients with an
acute DVT had an underlying venous disease in the unin-
volved contralateral limb. An ipsilateral post-thrombotic
limb was more likely to develop after an acute DVT in
patients with primary venous reflux, and the level of
venous dysfunction on the contralateral limb was an indi-
cation of the severity of disease developing in the ipsilat-
eral limb. However, the numbers in this study, especially
in group II (n = 17), were small, and these findings
require further investigation in a larger study.
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